Biogen
BIIB
BIIB
782 hedge funds and large institutions have $68.4B invested in Biogen in 2014 Q2 according to their latest regulatory filings, with 81 funds opening new positions, 275 increasing their positions, 302 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% less repeat investments, than reductions
Existing positions increased: 275 | Existing positions reduced: 302
25% less call options, than puts
Call options by funds: $814M | Put options by funds: $1.09B
Holders
782
Holding in Top 10
36
Calls
$814M
Puts
$1.09B
Top Buyers
| 1 | +$516M | |
| 2 | +$293M | |
| 3 | +$139M | |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$132M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$120M |
Top Sellers
| 1 | -$265M | |
| 2 | -$246M | |
| 3 | -$176M | |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$169M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$132M |